James Investment Research Inc. Has $3.84 Million Position in Danaher Co. (NYSE:DHR)

James Investment Research Inc. lessened its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 13.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,744 shares of the conglomerate's stock after selling 2,526 shares during the quarter. James Investment Research Inc.'s holdings in Danaher were worth $3,844,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Heck Capital Advisors LLC acquired a new position in shares of Danaher during the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new position in shares of Danaher during the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher during the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher during the fourth quarter worth approximately $31,000. Finally, Pineridge Advisors LLC boosted its holdings in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after buying an additional 57 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Ratings Changes

A number of analysts recently weighed in on DHR shares. StockNews.com cut shares of Danaher from a "buy" rating to a "hold" rating in a report on Saturday, December 14th. Stephens restated an "overweight" rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Citigroup reduced their target price on shares of Danaher from $285.00 to $265.00 and set a "buy" rating for the company in a report on Thursday, January 30th. Wolfe Research upgraded shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 target price for the company in a report on Thursday, October 31st. Finally, Barclays decreased their price objective on shares of Danaher from $275.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $278.00.

Danaher Trading Down 0.2 %

Shares of DHR traded down $0.50 on Wednesday, reaching $204.03. 3,043,050 shares of the company's stock were exchanged, compared to its average volume of 4,465,977. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $147.37 billion, a P/E ratio of 38.64, a price-to-earnings-growth ratio of 2.63 and a beta of 0.83. The business has a 50 day moving average price of $228.34 and a two-hundred day moving average price of $248.10. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm earned $2.09 earnings per share. Research analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher's payout ratio is presently 20.45%.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 10.90% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.